💡 Why Microchannel Technology Matters in Oncology Infusion ??

Blockage prevention is critical in chemotherapy drug infusion—especially with agents like 5-Fluorouracil (5-FU), which tend to crystallize and obstruct narrow tubing. To address this, S&S MED developed a patented microchannel technology designed specifically for oncology applications.

✔ 4.6 Times Larger Cross-Sectional Area

The microfluidic channel in Neofuser Onco is about 4.6 times wider in cross-sectional area than conventional 50µm capillaries.

✅ Result: Smooth and uninterrupted flow, even when infusing crystallization-prone drugs.

✔ Extended Channel Length for Flow Control

While increasing the cross-sectional area, the microchannel is also extended to 420 mm (vs. 15 mm in traditional capillaries) to maintain precise control over flow rate.

✅ Result: Accurate and steady drug delivery over time.

✔ Oncology-Specific Engineering

Neofuser Onco was developed exclusively for oncology drugs such as 5-FU and Trabectedin, incorporating a wide-channel flow regulator called micro-channel that minimizes delays due to micro-particle build-up.